The role of bone decortication in enhancing the results of guided bone regeneration: a literature review.

BACKGROUND: Bone decortication is often performed as part of a guided bone regeneration (GBR) procedure. The biologic rationale for decortication of bone is to allow progenitor cells easy access to a GBR-treated site and to facilitate prompt angiogenesis. It also may enhance the physical connection between a bone graft and a recipient site. However, the concept of decortication prior to a GBR procedure is controversial because there are no human clinical trials to support its effectiveness, and there are opposing points of view derived from animal studies regarding its usefulness. METHODS: The literature was assessed to determine whether there are enough data to validate the rationale for using decortication of bone as an integral part of GBR procedures. Eight searches were performed seeking controlled clinical trials that addressed the ability of decortication to enhance GBR. RESULTS: Three controlled animal clinical trials were found that supported the use of decortication prior to performing GBR. Two controlled animal clinical trials were located that indicated decortication did not improve GBR procedures. No human controlled clinical trial was identified that addressed the ability of decortication to alter GBR procedures. The literature addressing the capacity of decortication to affect onlay grafting or wound healing also provided mixed results. CONCLUSION: There is conflicting information and not enough clinical trials to make a definitive determination as to the merits of bone decortication prior to GBR procedures.

Enhanced coronary blood flow and abnormal blood flow in the aortic isthmus in severe fetal anemia.

Coronary arteries are not normally visualized by fetal echocardiograms. Reversal of flow in the transverse aortic arch is most often seen in association with severe coarctation. We describe a case of a near-term fetus whose fetal echocardiogram showed very prominent coronary arteries and severe reversal of flow in the transverse aorta suggestive of a coarctation who was postnatally confirmed to have normal intracardiac and aortic anatomy. We discuss the pitfalls in clinical diagnosis in this case to alert pediatric cardiologists of transient perturbations in physiology masquerading as heart disease.

Efficacy of subantimicrobial dosing with doxycycline. Point/counterpoint.

BACKGROUND: This article addresses the role of subantimicrobial dosing with doxycycline, or SDD, in the treatment of chronic periodontitis. The authors discuss and debate 10 issues with regard to SDD's utility as an adjunct to scaling and root planing. TYPES OF STUDIES REVIEWED: The authors reviewed reports of controlled clinical trials that assessed the efficacy of SDD. The main focus of this article is data from the U.S. Food and Drug Administration's phase 3 clinical trial that evaluated the efficacy of SDD in terms of alterations of probing depth, clinical attachment levels and disease progression. RESULTS: The authors compared data from test groups, which underwent root planing plus SDD, with data from control groups, which underwent root planing alone. The mean data suggest that SDD provides a defined but limited improvement of periodontal status when used in conjunction with scaling and root planing. Furthermore, several in vivo studies indicated that a nine-month course of SDD did not cause development of drug-resistant bacterial strains or alteration of the subgingival microbiota. CLINICAL IMPLICATIONS: Some patients may benefit from SDD. However, there are several issues that should be clarified before widespread use of SDD is recommended for patients with chronic periodontitis. The evidence indicates that suppression of the bacterial challenge, which reduces the host response, is the most efficient way to control periodontal diseases.

Position paper: sonic and ultrasonic scalers in periodontics. Research, Science and Therapy Committee of the American Academy of Periodontology.

Ultrasonic and sonic scalers appear to attain similar results as hand instruments for removing plaque, calculus, and endotoxin. Ultrasonic scalers used at medium power seem to produce less root surface damage than hand or sonic scalers. Due to instrument width, furcations may be more accessible using ultrasonic or sonic scalers than manual scalers. It is not clear whether root surface roughness is more or less pronounced following power-driven scalers or manual scalers. It is also unclear if root surface roughness affects long-term wound healing. Periodontal scaling and root planing includes thorough calculus removal, but complete cementum removal should not be a goal of periodontal therapy. Studies have established that endotoxin is weakly adsorbed to the root surface, and can be easily removed with light, overlapping strokes with an ultrasonic scaler. A significant disadvantage of power-driven scalers is the production of contaminated aerosols. Because ultrasonics and sonics produce aerosols, additional care is required to achieve and maintain good infection control when incorporating these instrumentation techniques into dental practice. Preliminary evidence suggests that the addition of certain antimicrobials to the lavage during ultrasonic instrumentation may be of minimal clinical benefit. However, more randomized controlled clinical trials need to be conducted over longer periods of time to better understand the long-term benefits of ultrasonic and sonic debridement.

Nonsurgical periodontal therapy in 2000: a literature review.

BACKGROUND: This article addresses the advantages and limitations of nonsurgical periodontal therapies to treat patients with mild-to-moderate chronic periodontitis. TYPES OF STUDIES REVIEWED: Controlled clinical trials were selected that assessed the efficacy of the following treatment methods: mechanical instrumentation, ultrasonic débridement, supragingival irrigation, subgingival irrigation, local drug delivery, administration of systemic antibiotics and host-response modulation. Evidently, data with regard to alterations of probing depth, clinical attachment levels and inflammatory status were evaluated. RESULTS: Comparison of the data from test and control groups revealed the following results. Manual and ultrasonic débridement can be used to treat most patients with mild-to-moderate chronic periodontitis. Patients who do not practice optimal plaque control can enhance their personal hygiene procedures by using supragingival irrigation. Subgingival irrigation usually does not provide any benefit beyond that achieved with root planing. Systemic and locally delivered antimicrobial agents appear to be most beneficial among patients who do not respond to conventional treatment. Host modulation may enhance root planing modestly. CLINICAL IMPLICATIONS: The data indicate that most patients with mild-to-moderate periodontitis can be treated with nonsurgical therapies. However, clinicians need to be aware of the limitations of each technique with regard to the magnitude of improvement that it can induce at specific sites.

Emdogain: evidence of efficacy.

This article addresses the use of enamel matrix proteins (Emdogain) to enhance regeneration of the periodontium. Information regarding the role of Emdogain to induce cementogenesis and histologic evidence in animals and humans that it can initiate regeneration of diseased sites are discussed. Several clinical trials have indicated that Emdogain plus modified Widman flap surgery provide a better result than the surgery alone. Several other investigations have indicated that flap surgery plus Emdogain or a bioabsorbable membrane achieve similar results. However, this latter finding needs further validation. Clinical examples of successful therapy with Emdogain are presented.

Changing periodontal paradigms: therapeutic implications.

Many paradigms concerning the epidemiology, pathogenesis, and systemic impact of periodontal diseases have been modified. For example, bacterial biofilms are essential to induce periodontitis, but their mere presence is not sufficient to initiate disease. It is also now recognized that the host response to these biofilms causes most of the destruction of the periodontal tissues. Codeterminants that influence the clinical severity of the disease process include environmental, genetic, and acquired factors. In general, the prevalence of advanced periodontitis and the incidence of disease progression are lower than previously believed. However, periodontitis remains the most common chronic illness. In addition, the finding that acquired systemic diseases may predispose individuals to periodontitis, and conversely that periodontitis may be a risk factor for certain systemic diseases, has expanded the scope of periodontics. These changed paradigms and their consequences with regard to selecting therapies are discussed in this review article.

Povidone-iodine's effects and role in the management of periodontal diseases: a review.

This review article addresses the effects of povidone-iodine (PVP-I) and its utility in the treatment of periodontal diseases. There are data to support the following statements: PVP-I is a potent antiseptic and, when used as a component in a rinse with H202, the rinse can decrease the level of gingivitis. With regards to patients with adult periodontitis, there is some evidence to indicate that PVP-I delivered via an ultrasonic device achieves better results in deep pockets than ultrasonic debridement when water is the irrigant. The benefits of PVP-I in the treatment of refractory periodontitis are unclear. Subgingival irrigation with PVP-I may reduce the incidence of bacteremia if it is employed as a pre-procedural intrasulcular irrigant; however, this technique is not recommended for high-risk patients. PVP-I is a safe antiseptic and does not appear to impede wound healing or induce resistant bacteria. It is an approved drug whose intraoral use is an unlabeled indication. In conclusion, the literature suggests that utilization of PVP-I is potentially beneficial in the management of some periodontal diseases. However, additional clinical trials are needed to verify this assessment, since it is based upon a limited number of studies.

Understanding a commercially available genetic susceptibility test for periodontitis.

This article addresses the biologic basis, data, and controversies associated with a commercially available genetic susceptibility test for adult periodontitis. Reviewed data suggest that patients who demonstrate specific alleles of the interleukin-1A and interleukin-1B genes are more prone to develop severe periodontitis than patients without these variations. In addition, numerous issues related to genetic evaluations are examined (e.g., odds ratios, longitudinal vs cross-sectional studies, screening vs management tests, predispositional testing for multifactorial diseases, and potential uses of genetic testing). Current recommendations suggest that clinicians proceed with caution when interpreting test results because many issues associated with genetic susceptibility testing for periodontitis need to be clarified before therapies are altered based on an uncertain future.

Conceptualization vs reality in the treatment of periodontal diseases.

This article addresses controversial issues associated with four different subjects: the usefulness of povidone iodine in the treatment of adult periodontitis, genetic susceptibility testing for severe periodontitis, local drug delivery in the treatment of periodontal diseases, and differentiating between statistical and clinical significance. Conclusions are drawn based on published evidence. Each subject is also assessed with regard to their practical application in the management of patients.

The role of Periostat in the management of adult periodontitis: a critical assessment.

This article addresses the role of Periostat in the treatment of adult periodontitis. Background information regarding the role of matrix metalloproteinases in the pathogenesis of periodontal diseases and the ability of tetracyclines to inhibit these enzymes are discussed. Data from large clinical trials concerning the benefits of using subantimicrobial doses of doxycycline are reviewed and critiqued with respect to their clinical significance. Overall, the mean data suggest that the use of Periostat provides a defined but limited improvement of periodontal status.

The role of local drug delivery in the management of periodontal diseases: a comprehensive review.

This review article evaluates the role of local drug delivery systems in the management of periodontal diseases. The efficacy of several local delivery devices (i.e., tetracycline fibers, metronidazole and minocycline gels, chlorhexidine chips, and doxycycline polymer) which are either commercially available in the United States or abroad, or are currently under consideration for Food and Drug Administration (FDA) approval are discussed. The drug delivery systems are assessed with regard to their functional characteristics, effectiveness as a monotherapy, as compared to scaling and root planing, and ability to enhance conventional therapy. Furthermore, controversies associated with local delivery are addressed (e.g., induction of bacterial resistant strains, the efficacy of systemic versus local drug delivery, and whether local drug delivery should function as an alternative or as an adjunct to conventional treatment).

Bacterial transmission in periodontal diseases: a critical review.

This review paper addresses intra- and extra-familial transfer of bacteria associated with periodontal diseases. Recent advances in molecular biology provide sensitive methods to differentiate organisms within the same species, thereby facilitating tracking routes of their transmission. Evidence for the passing of microorganisms between parents and children is particularly strong. In this regard, molecular genetic techniques have demonstrated that if a child is colonized by a potentially pathogenic species, then one of the parents will usually harbor genotypically identical bacteria. The data also indicate that transfer of bacteria between spouses occur, but it appears to happen infrequently. Saliva appears to be a major vector for bacterial transmission. However, the transfer of organisms does not necessarily result in colonization or infection of the host. Furthermore, individuals who harbor putative pathogens frequently do not manifest any signs of periodontal disease. This is attributed to host defenses, bacterial antagonism, and possibly lack of pathogenicity of infecting organisms. It is concluded, based upon current evidence, that periodontal pathogens are communicable; however, they are not readily transmissible.

Tetracycline fibers plus scaling and root planing versus scaling and root planing alone: similar results after 5 years.

This paper presents 5-year data pertaining to a subgroup of patients from a previous investigation who were treated with scaling and root planing plus tetracycline fibers. The parent study demonstrated that 6 months after therapy, scaling and root planing plus tetracycline fiber therapy was significantly better at reducing probing depth and gaining clinical attachment than scaling and root planing alone. However, the long-term data presented here show a regression from the original gains in clinical attachment levels in the fiber group. Ultimately, the use of fibers provided no significant advantage with regards to probing depth reduction or clinical attachment gain. Within the power of this study, which would have required 1.78 mm of change in clinical attachment to show a difference, there was no significant difference between the treatments at 5 years. This study underscores the need for additional long-term evaluation of this mode of therapy.

Contemporary interpretation of probing depth assessments: diagnostic and therapeutic implications. A literature review.

This paper addresses the diagnostic and therapeutic implications of increased probing depths. In general, in untreated and treated patients, when deep and shallow probing depths are compared, the data indicate that deep sites are associated with increased bleeding upon probing, elevated subgingival temperatures, higher levels of pathogens, more probing errors, a greater amount of infiltrated connective tissue, reduced ability to remove subgingival deposits with root planing, and diminished effectiveness of oral hygiene to alter the subgingival microbiota. Clinical trials demonstrate that probing depth is not a good predictor of future disease progression. However, deep sites are at greater risk of disease progression than shallow sites in untreated and treated patients. Furthermore, the deeper the probing depth, the greater the risk of future disease progression. Overall, the preponderance of evidence indicates that it is advantageous, but not always necessary, for patients to have shallow probing depths. With regards to surgical reduction of probing depths beyond that attained with non-surgical therapy, clinicians need to consider the advantages (e.g., ease of maintenance, reduced risk of disease progression) and disadvantages (e.g., root sensitivity, cosmetic defects) of treatment procedures. Since numerous variables require consideration (e.g., response to root planing, goals of therapy, acceptable level of risk for future disease progression), treatment decisions will vary depending on the patient and the desired clinical outcome at specific sites.